Avitinib (AC0010) 是一种不可逆的、突变体选择性的EGFR抑制剂，可有效抑制非小细胞肺癌中EGFR T790M耐药突变。阿比替尼也是一种新型BTK抑制剂。
| 生物活性 | Avitinib (AC0010) is an irreversible, mutant-selectiveEGFRinhibitor that effectively inhibitsEGFRT790M resistance mutations in non-small cell lungcancer(NSCLC). Abivertinib is also a novelBTKinhibitor. |
| Clinical Trial | |
| 分子量 | |
| Formula | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
